Diagnosis of advanced hepatocellular carcinoma using contrast-enhanced harmonic gray-scale imaging with enhancement agents (Levovist): Correlation with helical CT and US angiography
Tóm tắt
Từ khóa
Tài liệu tham khảo
Hisa N: Ultrasound Contrast AgentsJpn. J. Diag. Imaging 1999;19: 1258–1264 [in Japanese]
Blomley MJK, Albrecht T, Cosgrove DO, et al: Improved imaging of liver metastases with stimulated acoustic emission in the late phase of enhancement with the US contrast agent SH U 508 A. early experience.Radiology 1999;210: 409–416.
Ohto M, Matsutani S, Murayama N, et al: Evaluation of color Doppler signal enhancement with SH/TA-508, a newly developed ultrasound contrast agents in abdominal disease—Phase III clinical study—Jpn. J. Med. Imaging 1995;14: 196–211 [cmJapanese]
Goldberg BB, Liu J-B, Burns PN, et al: Galactose-based intravenous sonographic contrast agents.J Ultrasound Med 1993;12: 463–470.
Hosten N, Puls R, Lemke A-J, et al: Contrast-enhanced power Doppler sonography: improved detection of characteristic flow patterns in focal liver lesions.J Clin Ultrasound 1999;27: 107–115.
Choi BI, Kim TK, Han JK, et al: Vascularity of hepatocellular carcinoma: assessment with contrast-enhanced second-harmonic versus conventional power Doppler US.Radiology 2000;214: 381–386.
Kono Y, Moriyasu F, Mine Y, et al: Gray-scale socond harmonic imaging of the liver with galactose-based microbubbles.Investigative Radiology 1997;32: 120–125.
Kono Y, Moriyasu F, Nada T, et al: Gray-scale second harmonic imaging of the liver; A preliminary animal study.Ultrasound Med & Biol 1997;23: 719–726.
Kim TK, Choi BI, Han JK et al: Contrast agent-enhancement patterns with pulse-inversion harmonic US.Radiology 2000;216: 411–417.
Toyoda H, Kumada T, Nakano S, et al: Significance of tumor vascularity as a predictor of long-term prognosis in patients with small hepatocellular carcinoma treated by percutaneous ethanol injection therapy.J Hepatol 1997;26: 1055–1062.
Fukuda H: Tumor vascularity and lens culinaris agglutinin reactive α-fetoprotein are predictors of longterm prognosis in patients with hepatocellular carcinoma after percutaneous ethanol injection therapy.Kurume Med J 1998;45: 187–193.
Burns PN, Wilson SR, Muradali D, et al: Microbubble destruction is the origin of harmonic signals from FS 069.Radiology 1996;201 (P): 158–159.
Calliada F, Campani R, Bottinelli O, et al: Ultrasound contrast agents basic principles.Eur J Radiol 1998;27: 157–160.
Nanda N, Carstensen EL: Echo-enhancing agents safty. in: Nanda N, Schlief R, Goldberg BB, eds. Advances in echo imaging using contrast enhancement. 2nd ed. Lancaster, England: Kluwer Academic, 1997; pp. 115–131.
Wilson SR, Burns PN, Muradali D, et al: Harmonic hepatic US with microbubble contrast agents: initial experience showing improved characterization of hemangioma, hepatocellular carcinoma, and metastasis.Radiology 2000;215: 153–161.
Kudo M, Tomita S, Tochio H, et al: Hepatic focal nodular hyperplasia: specific findings at dynamic contrast-enhanced US with carbon dioxide microbubbles.Radiology 1991;179: 377–382.
Kudo M, Tomita S, Tochio H, et al: Small hepatocellular carcinoma: diagnosis with US angiography with intraarterial CO2 microbubbles.Radiology 1992;182: 155–160.
Chen RC, Wang CK, Chiang LC, et al: Intra-arterial carbon dioxide-enhanced ultrasonogram of hepatocellular carcinoma treated by transcatheter arterial embolization and percutaneous ethanol injection therapy.J Gastrol Hepatol 1998;13: 41–46.
Imari Y, Sakamoto S, Shiomiti S, et al Hepatocellular carcinoma not detected with plain US: treatment with intraarterial CO2 microbubbles.Radiology 1992;182: 155–160.
Takeshima K, Kumada T, Kimura T, et al: The usefulness of percutaneous ethanol injection therapy under guidance with carbon dioxide contrast enhanced ultrasound sonography.Nihon Rinsho 1998;56: 1001–1006 [in Japanese]